T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Veritone
VERI
$139M
| $354K | ﹤0.01% |
15,744
-343
| -2% | -$8.8K |
|
2527
Washington Trust Bancorp
WASH
$767M
| $354K | ﹤0.01% |
6,285
-281
| -4% | -$15.6K |
|
|
MGLN
2528
DELISTED
Magellan Health Services, Inc.
MGLN
| $353K | ﹤0.01% |
3,712
-2,492
| -40% | -$236K |
|
2529
Altimmune
ALT
$560M
| $350K | ﹤0.01% |
38,219
+5,900
| +18% | +$62.7K |
|
2530
CRA International
CRAI
$1.07B
| $350K | ﹤0.01% |
3,748
-97
| -3% | -$9.7K |
|
|
MAGN
2531
Magnera Corp
MAGN
$433M
| $350K | ﹤0.01% |
1,566
-55
| -3% | -$12K |
|
|
SP
2532
DELISTED
SP Plus Corporation
SP
| $347K | ﹤0.01% |
12,297
-457
| -4% | -$13.7K |
|
2533
Matrix Service
MTRX
$328M
| $346K | ﹤0.01% |
45,975
+5,500
| +14% | +$51.7K |
|
|
USAK
2534
DELISTED
USA Truck Inc
USAK
| $346K | ﹤0.01% |
17,400
-2,300
| -12% | -$43.7K |
|
|
DX
2535
Dynex Capital
DX
$3.23B
| $345K | ﹤0.01% |
20,636
-397
| -2% | -$6.89K |
|
2536
Banc of California
BANC
$3.11B
| $341K | ﹤0.01% |
17,396
-152
| -0.9% | -$3.08K |
|
|
MRC
2537
DELISTED
MRC Global
MRC
| $341K | ﹤0.01% |
49,512
-1,696
| -3% | -$13.3K |
|
2538
TaskUs
TASK
$667M
| $340K | ﹤0.01% |
+6,300
| New | +$344K |
|
|
MCBC
2539
DELISTED
Macatawa Bank Corp
MCBC
| $340K | ﹤0.01% |
38,601
-75
| -0.2% | -$641 |
|
2540
Mercer International
MERC
$33.8M
| $338K | ﹤0.01% |
28,225
+9,300
| +49% | +$103K |
|
2541
Artesian Resources
ARTNA
$369M
| $336K | ﹤0.01% |
7,260
-115
| -2% | -$4.83K |
|
2542
SiriusPoint
SPNT
$2.7B
| $336K | ﹤0.01% |
41,357
-28,516
| -41% | -$251K |
|
2543
Energy Recovery
ERII
$399M
| $335K | ﹤0.01% |
15,574
-800
| -5% | -$16.7K |
|
|
GOOD
2544
Gladstone Commercial Corp
GOOD
$641M
| $334K | ﹤0.01% |
12,958
-10,482
| -45% | -$238K |
|
2545
Gorman-Rupp
GRC
$2.11B
| $332K | ﹤0.01% |
7,442
+952
| +15% | +$40.7K |
|
|
GOEV
2546
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $332K | ﹤0.01% |
+93
| New | +$371K |
|
2547
Gildan
GIL
$10.6B
| $331K | ﹤0.01% |
7,807
+200
| +3% | +$7.92K |
|
2548
Kinross Gold
KGC
$31.9B
| $331K | ﹤0.01% |
57,037
| – | – |
|
2549
Omega Flex
OFLX
$291M
| $331K | ﹤0.01% |
2,609
-50
| -2% | -$6.65K |
|
|
VELO
2550
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
| $331K | ﹤0.01% |
+33,986
| New | +$333K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.